Athos Therapeutics launches a new AI platform, Athos Omics AI, to provide no-code, micro-analytics for drug, food, and ...
Stockhead on MSN
333D raises $1m to supercharge digital asset platform upgrade
ASX microcaps continue to find investor support, particularly those innovating in blockchain, digital assets and 3D ...
Joseph Alderman et al argue that predictive models in healthcare lack adequate oversight and regulation. They highlight the ...
The healthcare technology landscape continues to evolve at an unprecedented pace, driven by the convergence of digital transformation, cloud-native architectures, and intelligent automation. As ...
Gemini normalized the inflammatory response at the cellular level in stage 3 and 4 CKD patients – – Gemini could potentially revolutionize the treatment of acute and chronic inflammatory disease – ...
According to a new comprehensive report from The Insight Partners, the global connected health market is observing ...
The global In Vitro Diagnostics Quality Control Market, valued at US$1.58 billion in 2024, stood at US$1.65 billion in 2025 and is projected ...
What makes these accounts stand out are the bold bets they’ve placed on talent, decentralization, ESG, and purpose-driven ...
New Long-term Safety Data from the Completed Phase 3 SOLARIS Trial Support the Potential of Olanzapine LAI (TEV-'749) as the First Long-Acting Olanzapine Treatment Option for Schizophrenia with No PDS ...
Q2 returns were 9.4% (Gross) and 8.7% (Net) compared to the MSCI ACWI ex USA (Net TR) return of 12.0% and the MSCI ACWI ex ...
Discover a top Christian university in Minnesota, offering undergraduate and graduate programs with affordable tuition and ...
Returns in Q2 were 9.6% (Gross) and 8.8% (Net) compared to the Russell 1000 Growth Index return of 17.8% and the S&P 500 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback